UroGen Pharma URGN Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's deferred tax assets and other non-current assets?
- UroGen Pharma (URGN) reported deferred tax assets and other non-current assets of $7.49M in Q1 2026.
- How has UroGen Pharma's deferred tax assets and other non-current assets changed year-over-year?
- UroGen Pharma's deferred tax assets and other non-current assets increased by 1919.7% year-over-year, from $371K to $7.49M.
- What is the long-term trend for UroGen Pharma's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), UroGen Pharma's deferred tax assets and other non-current assets has grown at a 139.1% compound annual growth rate (CAGR), from $66K to $5.16M.